WELL Health Technologies Corp. (TSX: WELL) released today its preliminary results for Q1 2022. The company is expecting quarterly revenue “to be greater than $120.0 million”, up from Q4 2021’s revenue of $115.7 million.
The company is also anticipating operating adjusted EBITDA to be north of $20 million and free cash flow around $10 million. This comes after the firm recorded its first net income quarter in Q4.
“We are pleased to report that WELL is on the cusp of delivering its best-ever quarter of revenue performance in Q1 which is generally a quarter that is adversely affected by seasonality,” said CEO Hamed Shahbazi.
The preliminary financials is supported by the firm’s operating results, highlighted by a total of 772,093 omni-channel patient visits during the quarter.
WELL Health Technologies last traded at $4.39 on the TSX.
Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
